Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
55–80
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
women 55-80 years of age;
post-menopausal for \>=5 years;
ambulatory.
You may not be if
malignant disease diagnosed within the previous 10 years (except basal cell cancer that has been successfully removed);
breast cancer within the previous 20 years;
allergy to bisphosphonates;
previous treatment with an intravenous bisphosphonate at any time;
previous treatment with an oral bisphosphonate within the last 6 months, \>1 month of treatment within the last year, or \>3 months of treatment within the last 2 years.
Clareo Health | DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
